Patent 9730773 was granted and assigned to Maxillent on August, 2017 by the United States Patent and Trademark Office.
A method is provided that includes injecting, from a first side of a bone, through (a) exactly one bore that passes through the bone from the first side to a second side of the bone, and (b) into a cavity adjacent to the second side of the bone, a solid-liquid composition of solid particles and a physiological liquid solution. The physiological liquid solution is drained from the cavity and through the bore while passage of the solid particles of the solid-liquid composition is inhibited, such that the solid particles accumulate in the cavity.